Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding StudySammy Huygens, Bart Rijnders, Birgit C. P. Koch et al.|Clinical Pharmacokinetics|2024Cited by 5
Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulins: a phase I/II dose finding studySammy Huygens, Bart Rijnders, Ilona Kleine Budde et al.|medRxiv|2023Cited by 1